Skip to main content
Pharmafile

Is the Current EU Legal Framework for Orphan Medicines Fit for Purpose?

Autumn 2019
Authors
Maria Isabel ManleyDr. Chris Boyle

Maria Isabel Manley, partner and head of the UK Global Life Sciences Practice, and Chris Boyle, associate, at Sidley, discuss the impact of regulatory frameworks on medicines for rare diseases.

View Article

Contacts

Manley, Maria Isabel
合伙人律师
Boyle, Chris
合伙人律师

Capabilities

Suggested News & Insights

2026 Momentum Food and Beverage ExchangeOctober 6-7, 2026
活动
Shifting Expectations: FDA Takes a First Step Toward Making GRAS Notifications MandatoryAugust 12, 2026
Food, Drug and Medical Device Update
The Evolving Global Landscape for Orphan Drug ExclusivityJuly 28, 2026
Global Life Sciences Update
Sidley Shortlisted in 16 Categories at the LMG Life Sciences Americas Awards 2026July 20, 2026
荣誉
OIG Signals Further Support for Manufacturer-Sponsored Testing Programs with Fourth Favorable Advisory OpinionJuly 8, 2026
Global Life Sciences Update
盛德助力和誉医药与礼来公司达成19亿美元战略合作July 2, 2026
公告